Phoenix Biotech Acquisition Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.481712 million compared to USD 0.377997 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.015 USD | +2.53% | -13.72% | -91.14% |
1st Jan change | Capi. | |
---|---|---|
-91.14% | 14.58M | |
+10.56% | 115B | |
+12.04% | 106B | |
-4.21% | 24.69B | |
-1.66% | 21.97B | |
-4.64% | 19.27B | |
-10.57% | 17.56B | |
-39.36% | 17.32B | |
+6.23% | 14.03B | |
+33.73% | 12.13B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023